What measuring properly looks like
You are the only trial whose result applies to you. That makes measurement the whole game, and it means the question about a scale or a ring is not whether it extends life, but whether it can detect a real change in one person.
Six tools. What each reliably tells you, how often to read it, and the smallest change in each that is not just the measurement breathing.
Last reviewed: July 2026
A thermometer is not graded on whether it cures fever.
Everywhere else on this site, a letter grade answers one question: does this intervention change an outcome in human trials. That question is the wrong one to ask a dynamometer. A measuring tool is not a treatment, and grading it for efficacy would be a category error.
So these six are assessed on a different axis: precision. Can this instrument detect a real change in you, and how large does the change have to be before you should believe it?
Both axes matter and they give different answers. A continuous glucose monitor is graded C as an intervention, wearing one has not been shown to improve outcomes in people without diabetes. It is also an accurate glucose sensor. Those are two separate facts, and confusing them is how people end up either dismissing good instruments or buying unproven treatments.
Six tools, in the order the records use them.
The first three cost under a hundred dollars together and carry most of the value. Nothing here needs a subscription to be useful.
Body-weight scale
Body weight, and on smart models an estimate of body fat and muscle mass by bioimpedance.
Weight itself is the most reliable home measurement you own. It is a direct physical quantity, and a decent scale repeats to within a couple of hundred grams.
Day-to-day weight swings of 1 to 2 kg (2 to 4 lb) are normal and come from fluid, food volume and glycogen, not tissue. A single day's reading carries almost no information. The signal is the seven-day average moving over three to four weeks.
Do not read the bioimpedance body-fat or muscle-mass numbers as tissue measurements. Bioimpedance infers composition from how easily a current crosses your body, which is dominated by how hydrated you are. Those figures can move several percent overnight without any change in muscle or fat. If body composition matters to your decision, DEXA is the reference method and it is not a home measurement.
Upper-arm blood-pressure monitor
Systolic and diastolic blood pressure at rest.
One of the few home measurements with a direct, large, randomized outcome literature behind the thing it measures. Blood pressure is where measurement most reliably leads somewhere.
Single readings scatter substantially with posture, talking, caffeine, bladder and time of day. Clinical guidance is built on averaged readings across multiple days for exactly this reason. On properly averaged readings, movement under about 5 mmHg systolic should be treated as probably noise.
A wrist cuff is not accurate enough for decisions, and one alarming reading is not a pattern. A repeat after five minutes of sitting quietly is the meaningful one. Persistently high averaged readings are a clinician conversation, not a supplement decision.
Hand dynamometer (grip strength)
Maximal isometric grip force in kilograms.
The best value-for-money measurement in this list. Lower grip strength independently predicts all-cause, cardiovascular and cancer mortality across very large prospective cohorts, and EBL's biomarker A measurable sign in the body, such as a blood test value, used to track a condition or the effect of a treatment. entry carries those citations. It also responds to training, so it functions as both a risk marker and a progress marker.
A few kilograms of test-retest variation is normal, so standardize everything you can: same hand, seated, elbow at ninety degrees, same time of day, best of three. A change worth taking seriously is several kilograms sustained across two monthly readings, not one better squeeze.
Do not compare your number to a friend's. The published cut-points are sex-specific and population-referenced. EWGSOP2 uses under 27 kg for men and under 16 kg for women as the sarcopenia Age-related loss of muscle mass and strength. screening threshold, which is a floor to stay above rather than a target.
Sleep and heart-rate wearable
Sleep duration and timing, resting heart rate, heart-rate variability, and an estimated sleep-stage breakdown.
Resting heart rate and total sleep duration are the two outputs worth trusting. Both are relatively robust, both trend meaningfully over weeks, and both respond to training load, alcohol and illness.
Heart-rate variability swings widely night to night in the same healthy person, so a single night tells you essentially nothing; the seven-day rolling average against your own baseline month is the readable signal, and comparison against another person is not. Sleep-stage classification is the weakest output these devices produce: agreement with polysomnography for individual stages is poor, so treat the REM and deep-sleep breakdown as entertainment rather than data.
A readiness score is a rough estimate, and a deep-sleep percentage from a wearable is not a validated target. If unrefreshing sleep persists despite adequate hours, that is a clinician conversation: sleep apnea is common, underdiagnosed and treatable, and no ring will detect it.
Continuous glucose monitor
Interstitial glucose every few minutes, from which apps derive averages, variability and post-meal excursions.
As a learning instrument it is genuinely effective. Two weeks of wearing one teaches most people more about their own responses to specific meals than any amount of reading. That is a real and defensible use.
Modern sensors run in the region of 8 to 10 percent mean absolute relative difference against laboratory reference, and different sensors on the same person can sit offset from each other. So compare patterns within one sensor's life, not absolute numbers across sensors, and do not treat a reading as a laboratory value.
Do not conclude that flattening every post-meal rise improves your health. In people without diabetes, whether shaving glucose excursions changes any clinical outcome is genuinely unestablished, and that is the single biggest gap in the current glucose-optimization literature. EBL grades the CGM as an intervention on that basis; it is a good instrument and an unproven treatment.
Laboratory blood panel
The markers EBL publishes thresholds for, including ApoB Apolipoprotein B, a protein carried once on each cholesterol particle that can enter the artery wall, so it counts those particles directly., Lp(a) Lipoprotein(a), a cholesterol-carrying particle whose level is set largely by genetics., hs-CRP High-sensitivity C-reactive protein, a blood marker of low-grade inflammation., HbA1c A blood test that reflects average blood sugar over the previous two to three months., fasting insulin and vitamin D.
The only measurement in this list that is analytically standardized and clinically actionable across the board. Everything else on this page is context; this is the part your physician can act on.
Each marker carries both biological and analytical variation, and some markers move far more than others between draws. Fast when the marker requires it, use the same laboratory where you can, and draw at a similar time of day. The readable interval is the one the intervention was studied for; a twelve-week marker read at three weeks answers a different and usually unanswerable question.
A marker that sounds advanced adds nothing unless it answers a question. A test that will not change what you do is a test worth skipping, and a panel ordered without a plan for the results mostly generates anxiety.
The noise floors above are measurement practice, not graded trial findings. They describe how much each instrument moves on its own so you can tell a result from a fluctuation. They are not clinical thresholds and they are not advice about what to do with a number.
Owning the tools is not the method. The method is baseline, change one thing, retest, and knowing your noise floor is what makes the retest mean something.
Six steps that separate a self-experiment that can answer your question from one that cannot.
A 20-question intake, then a printable brief of labs and doses to take to your physician.
Each marker has an evidence-based recheck window. Reading it early answers a different question.
The grades narrow the field so your one experiment is not spent at random.
Educational use only · Not medical advice. Nothing here is a recommendation to start, stop or change any supplement or prescription, and no home measurement diagnoses anything. Those decisions belong to you and your clinician. See EBL's Position.